Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation

Molecular Therapy

Volumn 20, Issue 1, 2012, Pages 14-20

  Prockop, Darwin J ^a   Youn Oh, Joo ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; HYPOCALCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; NITRIC OXIDE; PROSTAGLANDIN E2; STANNIOCALCIN 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA STIMULATE GENE PROTEIN 6; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CORNEA INJURY; CORNEA OPACITY; CYTOKINE RELEASE; DRUG MECHANISM; HEART INFARCTION; HUMAN; INFLAMMATION; LUNG INJURY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PERITONITIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPSIS; SIGNAL TRANSDUCTION;

EID: 84856973179     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.211     Document Type: Review

References (46)

1. Berg, RD (1996). The indigenous gastrointestinal microflora. Trends Microbiol 4: 430-435. (Pubitemid 26373240)
2. Savage, DC (1977). Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31: 107-133.
3. Nathan, C and Ding, A (2010). Nonresolving inflammation. Cell 140: 871-882.
4. Chen, GY and Nuñez, G (2010). Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10: 826-837.
5. Serhan, CN, Chiang, N and Van Dyke, TE (2008). Resolving inflammation: dual antiinflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349-361. (Pubitemid 351595216)
6. Gordon, S and Martinez, FO (2010). Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604.
7. Izcue, A, Coombes, JL and Powrie, F (2009). Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 27: 313-338.
8. Wan, YY (2010). Regulatory T cells: immune suppression and beyond. Cell Mol Immunol 7: 204-210.
9. Bianco, P, Sacchetti, B and Riminucci, M (2011). Osteoprogenitors and the hematopoietic microenvironment. Best Pract Res Clin Haematol 24: 37-47.
10. Méndez-Ferrer, S, Michurina, TV, Ferraro, F, Mazloom, AR, Macarthur, BD, Lira, SA et al. (2010). Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829-834.
11. Prockop, DJ, Kota, DJ, Bazhanov, N and Reger, RL (2010). Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J Cell Mol Med 14: 2190-2199.
12. Rock, KL, Latz, E, Ontiveros, F and Kono, H (2010). The sterile inflammatory response. Annu Rev Immunol 28: 321-342.
13. Eigenbrod, T, Park, JH, Harder, J, Iwakura, Y and Núñez, G (2008). Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1released from dying cells. J Immunol 181: 8194-8198.
14. Soehnlein, O and Lindbom, L (2010). Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10: 427-439.
15. Uccelli, A and Prockop, DJ (2010). Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr Opin Immunol 22: 768-774.
16. Tolar, J, Villeneuve, P and Keating, A (2011). Mesenchymal stromal cells for graftversus-host disease. Hum Gene Ther 22: 257-262.
17. English, K and Mahon, BP (2011). Allogeneic mesenchymal stem cells: agents of immune modulation. J Cell Biochem 112: 1963-1968.
18. Singer, NG and Caplan, AI (2011). Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 6: 457-478.
19. Ortiz, LA, Dutreil, M, Fattman, C, Pandey, AC, Torres, G, Go, K et al. (2007). Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104: 11002-11007. (Pubitemid 47175216)
20. Ortiz, LA, Gambelli, F, McBride, C, Gaupp, D, Baddoo, M, Kaminski, N et al. (2003). Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100: 8407-8411. (Pubitemid 36842558)
21. Ortiz, LA, Moroz, K, Liu, JY, Hoyle, GW, Hammond, T, Hamilton, RF et al. (1998). Alveolar macrophage apoptosis and TNF-β, but not p53, expression correlate with murine response to bleomycin. Am J Physiol 275(6 Pt 1): L1208-L1218.
22. Chen, CJ, Kono, H, Golenbock, D, Reed, G, Akira, S and Rock, KL (2007). Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13: 851-856. (Pubitemid 47038190)
23. Medzhitov, R (2008). Origin and physiological roles of inflammation. Nature 454: 428-435.
24. Yagi, H, Soto-Gutierrez, A, Navarro-Alvarez, N, Nahmias, Y, Goldwasser, Y, Kitagawa, Y et al. (2010). Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther 18: 1857-1864.
25. Lee, RH, Pulin, AA, Seo, MJ, Kota, DJ, Ylostalo, J, Larson, BL et al. (2009). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5: 54-63.
26. Lee, RH, Seo, MJ, Pulin, AA, Gregory, CA, Ylostalo, J and Prockop, DJ (2009). The CD34-like protein PODXL and α6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice. Blood 113: 816-826.
27. Roddy, GW, Oh, JY, Lee, RH, Bartosh, TJ, Ylöstalo, JH, Coble, K et al. (2011). Action at a distance: Systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TSG-6. Stem Cells 29: 1572-1579.
28. Oh, JY, Roddy, GW, Choi, H, Lee, RH, Ylöstalo, JH, Rosa, RH Jr et al. (2010). Antiinflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci USA 107: 16875-16880.
29. Choi, H, Lee, RH, Bazhanov, N, Oh, JY and Prockop, DJ (2011). Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-βB signaling in resident macrophages. Blood 118: 330-338.
30. Seong, SY and Matzinger, P (2004). Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 4: 469-478. (Pubitemid 38745558)
31. Bauernfeind, FG, Horvath, G, Stutz, A, Alnemri, ES, MacDonald, K, Speert, D et al. (2009). Cutting edge: NF-βB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183: 787-791.
32. Németh, K, Leelahavanichkul, A, Yuen, PS, Mayer, B, Parmelee, A, Doi, K et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-49.
33. Ulloa, L and Tracey, KJ (2005). The "cytokine profile": a code for sepsis. Trends Mol Med 11: 56-63.
34. Medzhitov, R (2010). Inflammation 2010: new adventures of an old flame. Cell 140: 771-776.
35. Mei, SH, Haitsma, JJ, Dos Santos, CC, Deng, Y, Lai, PF, Slutsky, AS et al. (2010). Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 182: 1047-1057.
36. Prockop, DJ, Brenner, M, Fibbe, WE, Horwitz, E, Le Blanc, K, Phinney, DG et al. (2010). Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 12: 576-578.
37. Kim, J and Hematti, P (2009). Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 37: 1445-1453.
38. Maggini, J, Mirkin, G, Bognanni, I, Holmberg, J, Piazzón, IM, Nepomnaschy, I et al. (2010). Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS ONE 5: e9252.
39. Zhang, QZ, Su, WR, Shi, SH, Wilder-Smith, P, Xiang, AP, Wong, A et al. (2010). Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 28: 1856-1868.
40. So, A, De Smedt, T, Revaz, S and Tschopp, J (2007). A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 9: R28.
41. Gabay, C, Lamacchia, C and Palmer, G (2010). IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 6: 232-241.
42. Wisniewski, HG and Vilcek, J (2004). Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. Cytokine Growth Factor Rev 15: 129-146. (Pubitemid 38521249)
43. Milner, CM, Higman, VA and Day, AJ (2006). TSG-6: a pluripotent inflammatory mediator? Biochem Soc Trans 34(Pt 3): 446-450. (Pubitemid 43954008)
44. Block, GJ, Ohkouchi, S, Fung, F, Frenkel, J, Gregory, C, Pochampally, R et al. (2009). Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells 27: 670-681.
45. Wang, Y, Huang, L, Abdelrahim, M, Cai, Q, Truong, A, Bick, R et al. (2009). Stanniocalcin-1 suppresses superoxide generation in macrophages through induction of mitochondrial UCP2. J Leukoc Biol 86: 981-988.
46. Fang, L, Gao, XM, Moore, XL, Kiriazis, H, Su, Y, Ming, Z et al. (2007). Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol 43: 535-544. (Pubitemid 47615041)